References
- Chavanet P, Bon none B, Guiguet M, Zeller V, So lary E, Maurice L, Casasnovas O, Caillot D, Waldner A, Kisterman JP, Portoer H. High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitis. J Infect Dis 1992; 166: 428–431
- Aka lin H, Akd is AC, Mistik R, Helvaci 5, Kilicturgay K. Cerebrospinal fluid interleukin-1Ninterleukin-1 receptor antagonist balance and tumor necrosis factor-a concentrations in tuberculous, viral and acute bacterial meningitis. ScandJ Infect Dis 1994; 26: 667–674
- Dulkerian SJ, Kilpatrick L, Costarino AT Jr, McCawley L, Fein J, Corcoran L, Zirin 5, Harris MC. Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr 1995; 126: 872–876
- Lopez-Cortes LF, Cruz-Ruiz M, Gomez-Mateos J, Viciana-Fernan-dez P, Martinez-Marcos FJ, Pachon J. Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: Its possible role as neutroph i I chemotactic factor. J Infect Dis 1995; 172: 581–584
- Ichiyama T, Hayashi T, Nishikawa M, Furukawa S. Levels of transforming growth factor $1, tumor necrosis factor a, and interleukin 6 in cerebrospinal fluid: Association with clinical outcome for children with bacterial meningitis. Clin Infect Dis 1997; 25: 328–329
- Conan MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvementof four KB-like motifs and of constitutive and inducible forms of NF-KB. Mol Cell Biol 1990; 10: 1498–1506
- Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-KB transcription factor. Mol Cell Biol 1998; 10: 2327–2334
- Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, Fenton M. Characteriza-tion of a functional NF-KB site in the human interleukin 1f3 promotor: Evidence for a positive autoregulatory loop. Mol Cell Biol 1993; 13: 6231–6240
- Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-1L6 and NF-KB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993; 90: 10193-10197
- Kunsch C, Lang RK, Rosen CA, Shannon MF. Synergistic transcriptional activation of the IL-8 gene by NF-KB p65 (RelA) and NF-IL-6. J Immuno 11994; 153: 153-164
- Baldwin AS Jr. The NF-KB and IKB proteins: New discoveries and insights. Annu Rev Immuno 11996; 14: 649-683
- Ichiyama T, Zhao H, Catania A, Furukawa 5, Lipton JM. a-Melanocyte-stimulating hormone inhibits NF-KB activation and IKBa degradation in human glioma cells and in experimental brain inflammaton. Exp Neurol 1999; 157: 359–365
- Tak PP, Firestein GS. NF-KB: A key role in inflammatory diseases. J Clin Invest 2001; 107: 7-11
- Han ZN, Boyle DL, Manning AM, Firestein GS. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 1998; 28: 197-208
- Hart LA, Krishnan VL, Adcock IM, Barnes PJH, Chung KF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respr Crit Care Med 1998; 158: 1585-1592
- Ossege LM, Sindern E, Voss B, Malin JP. Expression of tumor necrosis factor-a and transforming growth factor-P.1 in cerebro-spinal fluid cells in meningitis. J Neurol Sci 1996; 144: 1–13
- Diab A, Zhu J, Lindquist L, Wretlind B, Link H, BakhietM. Cytokine mRNA profiles during the course of experimental Haemophilus influenzae bacterial meningitis. Clin Immunol Immunopathol 1997; 85: 236–245